Keyphrases
Sialylation
100%
GNE Myopathy
100%
Congenital Disorders of Glycosylation
50%
Review Update
50%
Immunopathology
50%
Glycosylation
30%
Oxidative muscle
14%
Regeneration Pathway
14%
GNE Gene
14%
GNE mutations
14%
Sialic Acid Biosynthesis
14%
Muscle Regeneration
14%
Sialic Acid Metabolism
14%
Hyposialylation
14%
Presentation Strategies
14%
Muscle Atrophy
14%
Clinical Presentation
14%
Glycoprotein
14%
Target Pathways
14%
Glycolipids
14%
Bifunctional Enzyme
14%
Emerging Therapeutics
14%
Therapeutic Target
14%
Cytoskeletal Dynamics
14%
Clinical Treatment
14%
Clinical Development
14%
Dysregulation
14%
Non-canonical
14%
Quality of Life Improvement
14%
Disease Spectrum
14%
Targeted Therapy
14%
Therapeutic Strategies
14%
Oxidative Stress
14%
Patient Well-being
14%
Muscle Weakness
14%
Rare Disorders
14%
Clinical Outcomes
14%
Pathophysiology
14%
Phosphomannomutase 2
11%
Immune Dysfunction
11%
Genetic Disease
5%
Biological Processes
5%
Standard of Care
5%
Glycans
5%
Microorganisms
5%
Susceptibility to Infection
5%
Host-pathogen
5%
Immune Response
5%
Abnormal Glycosylation
5%
Glycosylation Pattern
5%
Biochemistry, Genetics and Molecular Biology
Sialylation
100%
Sialic Acid
100%
Targeted Therapy
50%
Glycosylation
50%
Dynamics
50%
Metabolic Pathway
50%
Muscle Regeneration
50%
GNE (Gene)
50%
Enzyme
50%
Glycolipid
50%
Glycoprotein
50%
Anabolism
50%
Oxidative Stress
50%
Neuroscience
Muscle Disorder
100%
Sialic Acid
28%
Glycoprotein
14%
Muscle Atrophy
14%
Glycosylation
14%
Quality of Life
14%
Glycolipid
14%
Oxidative Stress
14%
Anabolism
14%
Metabolic Pathway
14%